International Assets Investment Management LLC Takes $96,000 Position in UiPath Inc. (NYSE:PATH)

International Assets Investment Management LLC purchased a new position in shares of UiPath Inc. (NYSE:PATH) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 7,565 shares of the healthcare company’s stock, valued at approximately $96,000.

Several other institutional investors have also added to or reduced their stakes in PATH. Vanguard Group Inc. lifted its holdings in shares of UiPath by 5.6% in the first quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock worth $911,741,000 after acquiring an additional 2,133,078 shares during the last quarter. Swiss National Bank increased its position in UiPath by 4.9% during the 4th quarter. Swiss National Bank now owns 1,211,500 shares of the healthcare company’s stock worth $30,094,000 after purchasing an additional 56,600 shares in the last quarter. State Board of Administration of Florida Retirement System lifted its stake in UiPath by 0.5% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock valued at $6,696,000 after purchasing an additional 1,571 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp lifted its stake in UiPath by 4.2% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock valued at $5,240,000 after purchasing an additional 9,393 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its position in UiPath by 245.1% in the first quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock valued at $1,032,000 after buying an additional 32,456 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Bank of America reiterated a “neutral” rating and set a $16.00 price target (down from $30.00) on shares of UiPath in a report on Thursday, May 30th. BMO Capital Markets dropped their target price on UiPath from $28.00 to $14.00 and set a “market perform” rating for the company in a research report on Monday, June 3rd. TD Cowen reissued a “hold” rating and set a $17.00 price target (down from $28.00) on shares of UiPath in a research note on Thursday, May 30th. KeyCorp reaffirmed a “sector weight” rating on shares of UiPath in a research note on Thursday, May 30th. Finally, Barclays cut their target price on shares of UiPath from $16.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Monday, August 19th. Sixteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $17.94.

UiPath Trading Down 2.2 %

PATH stock opened at $12.60 on Wednesday. The firm has a market cap of $7.22 billion, a PE ratio of -78.75 and a beta of 0.86. The stock has a 50-day moving average price of $12.21 and a 200-day moving average price of $16.86. UiPath Inc. has a 1-year low of $10.37 and a 1-year high of $27.87.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.